GrayMatters Health (גריי מאטרס הלת' בע~מ)
Haifa, Israel
GrayMatters Health (GMH) develops digital self-neuromodulation therapeutics for mental disorders to help patients regain agency over their emotion regulation. GMH offers Prism, a non-invasive adjunct therapeutic that utilizes novel neuroscience-based and brain-mechanism-specific biomarkers. The company's first product candidate, Prism for PTSD, is undergoing clinical investigation in five sites across the United States and Israel, to demonstrate its efficacy and safety as an adjunct to standard PTSD treatments.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- www.graymatters-health.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of GrayMatters Health (גריי מאטרס הלת' בע~מ)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now